Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
19.95
+0.17 (0.86%)
At close: Jun 16, 2025, 4:00 PM
19.78
-0.17 (-0.85%)
After-hours: Jun 16, 2025, 7:56 PM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $14.82 billion as of June 16, 2025. Its market cap has increased by 619.13% in one year.
Market Cap
14.82B
Enterprise Value
14.46B
1-Year Change
619.13%
Ranking
Category
Stock Price
$19.95
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $14.82B, an increase of 12,350.58%. That is a compound annual growth rate of 59.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 14.69B | 11.63% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |